GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

Operating loss: $3.5 million, compared to an operating loss of $3.6 million for the second quarter of fiscal 2024.

The LineaIVT platform combines DNA IVT template manufacturing via the LineaDNA platform with a proprietary RNA polymerase, LineaRNAP™, to enable mRNA and ... chain reaction ("PCR") to enable ...

Abstract: To achieve efficient messenger ribonucleic acid (mRNA ... reaction mixture without high-speed centrifugation, solvents, and cooling conditions by using mRNA-probe-coated magnetic beads, ...

The Company also announced that it is actively negotiating a supply agreement for GMP IVT template with a mRNA therapeutic developer ... Using the polymerase chain reaction ("PCR") to enable ...

- Signals Start of New Commercialization Phase for LineaRx Subsidiary - ...

These custom mRNA construct libraries enable the testing ... of a recombinant gene regulated by the T7 promoter. During the IVT reaction, dsRNA can be produced as a byproduct and trigger ...

Using the polymerase chain reaction ('PCR') to enable both the production and ... reduce the unwanted creation of double-stranded RNA (dsRNA) impurities within the IVT-mRNA synthesis process without ...

The Linea IVT platform combines DNA IVT templates manufacturing via the Linea DNA platform with a proprietary Linea™ RNAP to enable mRNA and sa ... the polymerase chain reaction ("PCR") to ...